DK1261603T3 - Flavonderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel - Google Patents
Flavonderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddelInfo
- Publication number
- DK1261603T3 DK1261603T3 DK01909906T DK01909906T DK1261603T3 DK 1261603 T3 DK1261603 T3 DK 1261603T3 DK 01909906 T DK01909906 T DK 01909906T DK 01909906 T DK01909906 T DK 01909906T DK 1261603 T3 DK1261603 T3 DK 1261603T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug
- processes
- preparation
- flavone derivatives
- flavone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0002528A FR2805538B1 (fr) | 2000-02-29 | 2000-02-29 | Nouveaux derives de flavones, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
| PCT/FR2001/000561 WO2001064673A1 (fr) | 2000-02-29 | 2001-02-27 | Derives de flavones, leur procede de preparation, leur application a titre de medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK1261603T3 true DK1261603T3 (da) | 2006-12-27 |
| DK1261603T5 DK1261603T5 (da) | 2007-07-09 |
Family
ID=8847520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01909906T DK1261603T5 (da) | 2000-02-29 | 2001-02-27 | Flavonderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20030119816A1 (da) |
| EP (1) | EP1261603B1 (da) |
| JP (1) | JP5118282B2 (da) |
| AR (1) | AR029479A1 (da) |
| AT (1) | ATE336490T1 (da) |
| AU (1) | AU783663B2 (da) |
| CA (1) | CA2403424C (da) |
| CY (1) | CY1105786T1 (da) |
| DE (1) | DE60122295T2 (da) |
| DK (1) | DK1261603T5 (da) |
| ES (1) | ES2270984T3 (da) |
| FR (1) | FR2805538B1 (da) |
| MY (1) | MY159418A (da) |
| PT (1) | PT1261603E (da) |
| TW (1) | TWI282338B (da) |
| WO (1) | WO2001064673A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2493871T3 (da) * | 2009-10-30 | 2014-11-10 | Prestwick Chemical Sas | Nye oximderivater samt deres anvendelse som allosteriske modulatorer af metabotropiske glutamatreceptorer |
| CN103896895A (zh) * | 2013-12-31 | 2014-07-02 | 浙江工业大学 | 一种香豆素衍生物的制备方法 |
| WO2018094275A1 (en) * | 2016-11-18 | 2018-05-24 | Tolero Pharmaceuticals, Inc. | Alvocidib prodrugs and their use as protein kinase inhibitors |
| US11497756B2 (en) | 2017-09-12 | 2022-11-15 | Sumitomo Pharma Oncology, Inc. | Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib |
| CN113490499A (zh) | 2018-12-04 | 2021-10-08 | 大日本住友制药肿瘤公司 | 用作治疗癌症的活性剂的cdk9抑制剂及其多晶型物 |
| US11793802B2 (en) | 2019-03-20 | 2023-10-24 | Sumitomo Pharma Oncology, Inc. | Treatment of acute myeloid leukemia (AML) with venetoclax failure |
| CN111057035B (zh) * | 2019-11-05 | 2021-10-26 | 中国人民解放军第二军医大学 | 一种黄芩素衍生物及其制备方法与应用 |
| GB202104122D0 (en) * | 2021-03-24 | 2021-05-05 | Floratek Pharma Ag | Compounds and their use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN164232B (da) * | 1986-04-11 | 1989-02-04 | Hoechst India | |
| DE3836676A1 (de) * | 1988-10-28 | 1990-05-03 | Hoechst Ag | Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel |
| US5733920A (en) * | 1995-10-31 | 1998-03-31 | Mitotix, Inc. | Inhibitors of cyclin dependent kinases |
| US5908934A (en) * | 1996-09-26 | 1999-06-01 | Bristol-Myers Squibb Company | Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs |
-
2000
- 2000-02-29 FR FR0002528A patent/FR2805538B1/fr not_active Expired - Fee Related
-
2001
- 2001-02-27 EP EP01909906A patent/EP1261603B1/fr not_active Expired - Lifetime
- 2001-02-27 ES ES01909906T patent/ES2270984T3/es not_active Expired - Lifetime
- 2001-02-27 US US10/181,677 patent/US20030119816A1/en not_active Abandoned
- 2001-02-27 PT PT01909906T patent/PT1261603E/pt unknown
- 2001-02-27 TW TWNEWDERIVA patent/TWI282338B/zh not_active IP Right Cessation
- 2001-02-27 JP JP2001563513A patent/JP5118282B2/ja not_active Expired - Fee Related
- 2001-02-27 AU AU37501/01A patent/AU783663B2/en not_active Ceased
- 2001-02-27 MY MYPI20010863A patent/MY159418A/en unknown
- 2001-02-27 CA CA2403424A patent/CA2403424C/fr not_active Expired - Fee Related
- 2001-02-27 AT AT01909906T patent/ATE336490T1/de active
- 2001-02-27 WO PCT/FR2001/000561 patent/WO2001064673A1/fr active IP Right Grant
- 2001-02-27 DE DE60122295T patent/DE60122295T2/de not_active Expired - Lifetime
- 2001-02-27 DK DK01909906T patent/DK1261603T5/da active
- 2001-02-28 AR ARP010100941A patent/AR029479A1/es not_active Application Discontinuation
-
2006
- 2006-11-15 CY CY20061101663T patent/CY1105786T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5118282B2 (ja) | 2013-01-16 |
| ATE336490T1 (de) | 2006-09-15 |
| ES2270984T3 (es) | 2007-04-16 |
| MY159418A (en) | 2017-01-13 |
| FR2805538A1 (fr) | 2001-08-31 |
| EP1261603A1 (fr) | 2002-12-04 |
| DE60122295D1 (de) | 2006-09-28 |
| US20030119816A1 (en) | 2003-06-26 |
| CA2403424C (fr) | 2011-02-01 |
| TWI282338B (en) | 2007-06-11 |
| AR029479A1 (es) | 2003-07-02 |
| PT1261603E (pt) | 2007-01-31 |
| DE60122295T2 (de) | 2007-11-15 |
| EP1261603B1 (fr) | 2006-08-16 |
| CY1105786T1 (el) | 2011-02-02 |
| WO2001064673A1 (fr) | 2001-09-07 |
| JP2003525290A (ja) | 2003-08-26 |
| AU3750101A (en) | 2001-09-12 |
| AU783663B2 (en) | 2005-11-24 |
| FR2805538B1 (fr) | 2006-08-04 |
| DK1261603T5 (da) | 2007-07-09 |
| CA2403424A1 (fr) | 2001-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1294682T3 (da) | Acylphenylurinstofderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
| DK1218341T3 (da) | Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
| DK2298769T3 (da) | Xanthinderivater, deres fremstilling og deres anvendelse som lægemiddel | |
| NO20040680L (no) | Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel | |
| DK1381605T3 (da) | Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse | |
| NO20035298D0 (no) | CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler | |
| DK1562946T5 (da) | Nye xanthinderivater, deres fremstilling og deres anvendelse som lægemiddel | |
| NO20014013D0 (no) | 16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse | |
| NO20030302L (no) | Nye heteroarylderivater og deres anvendelse som medikamenter | |
| NO20032733L (no) | Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse | |
| NO20024175D0 (no) | Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme | |
| DK1445252T3 (da) | Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter | |
| DK1083171T3 (da) | Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter | |
| DK1337529T3 (da) | Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem | |
| NO20044322L (no) | Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament | |
| NO20025357L (no) | Antranylamider og deres anvendelse som legemidler | |
| NO20025029L (no) | Nye epotilonderivater, fremgangsmÕte for fremstilling derav og deres farmasöytiske anvendelse | |
| DK1370550T3 (da) | Quinolylpropylpiperidinderivater, deres fremstilling og præparater indeholdende dem | |
| NO20043349L (no) | Kumarinderivater, fremgangsmate for deres framstilling og anvendelse derav | |
| NO20031838D0 (no) | Benzokazinonderivater, deres fremstilling og anvendelse | |
| DK1387838T3 (da) | Cyanoanthranylamid-derivater og deres anvendelse som lægemidler | |
| DK1406899T3 (da) | Phenylacetamidothiazolderivater, fremgangsmåder til deres fremstilling og deres anvendelse som antitumormidler | |
| NO20010219L (no) | Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel | |
| DK1261603T3 (da) | Flavonderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
| DK1200444T3 (da) | Nye xanthon-forbindelser, deres fremstilling og anvendelse som lægemiddel |